HEALTH● LOW1h ago · Sep 14, 2026, 3:58 PM
Definium rises as LSD pill achieves primary goal in late-stage trial for anxiety
Seeking Alpha Tech · global
Definium's stock rose following the successful achievement of primary goals in a late-stage clinical trial for an LSD pill designed to treat anxiety. This indicates progress in psychedelic-assisted therapy research.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoStakeholders seek stronger investment to reduce maternal, newborn deathsPremium TimesHEALTH1h agoBoiling bay leaves: why it is recommended and what are the benefitsClarínHEALTH2h agoJose Ruiz, coach, on how to take care of mobility: 'If at 60 years old you can keep your heels up for 10 consecutive raises, we can improve stability and walk more safely'ClarínHEALTH2h agoNo end in sight to Sudan's worsening public health crisis?Africanews [en]